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Animals and fungi produce cholesterol and
ergosterol, respectively, while plants produce the
phytosterols stigmasterol, campesterol, and b-
sitosterol in various combinations. The recent
sequencing of many algal genomes allows the
detailed reconstruction of the sterol metabolic
pathways. Here, we characterized sterol synthesis in
two sequenced Chlorella spp., the free-living C.
sorokiniana, and symbiotic C. variabilis NC64A.
Chlamydomonas reinhardtii was included as an internal
control and Coccomyxa subellipsoidea as a plant-like
outlier. We found that ergosterol was the major sterol
produced by Chlorella spp. and C. reinhardtii, while C.
subellipsoidea produced the three phytosterols found
in plants. In silico analysis of the C. variabilis NC64A,
C. sorokiniana, and C. subellipsoidea genomes
identified 22 homologs of sterol biosynthetic genes
from Arabidopsis thaliana, Saccharomyces cerevisiae,
and C. reinhardtii. The presence of CAS1, CPI1, and
HYD1 in the four algal genomes suggests the higher
plant cycloartenol branch for sterol biosynthesis,
confirming that algae and fungi use different
pathways for ergosterol synthesis. Phylogenetic
analysis for 40 oxidosqualene cyclases (OSCs)
showed that the nine algal OSCs clustered with the
cycloartenol cyclases, rather than the lanosterol
cyclases, with the OSC for C. subellipsoidea positioned
in between the higher plants and the eight other
algae. With regard to why C. subellipsoidea produced
phytosterols instead of ergosterol, we identified 22
differentially conserved positions where C.
subellipsoidea CAS and A. thaliana CAS1 have one
amino acid while the three ergosterol producing
algae have another. Together, these results
emphasize the position of the unicellular algae as an
evolutionary transition point for sterols.
Key index words: algal sterol composition; Chlorella
sorokiniana; Chlorella variabilis NC64A; Clotrimazole;
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Sterols are a type of lipid found within the mem-
brane of animals, fungi, and plants and contribute
to membrane stability and other important cellular
functions (He et al. 2003). Sterols are found in
many forms: free sterols, sterol esters, sterol alkyl
ethers, sterol sulfates, or linked to a glycoside moi-
ety (Benveniste 2004). As integral components of
the cell membrane, free sterols are crucial for the
integrity, fluidity, and permeability of the lipid
bilayer (Benveniste 2004). In addition to their
importance for cell membrane stability, they affect
membrane-bound protein composition and influ-
ence the functionality of enzymes, receptors, and
channels (Porsbring et al. 2009) and play an impor-
tant role in host defense during viral infection
(Blanc et al. 2011).
Interestingly, despite their consistent presence,
sterols are found in distinctly different compositions
between the kingdoms. Whereas cholesterol is the
primary zoosterol, ergosterol is the principal mycos-
terol, and separately, a handful of phytosterols such
as stigmasterol, campesterol, and b-sitosterol domi-
nate the plant membrane. In all cases, sterol biosyn-
thesis occurs in the endoplasmic reticulum (ER)
through a functional complex of enzymes that dis-
play specific protein-protein interactions. In fungi,
this complex of enzymes has been termed the “ergo-
some” (Mo and Bard 2005). In comparison, the
sterol biosynthetic pathway present in plants differs
from fungi and animals because plants produce a
wide variety of phytosterols and intermediates in the
phytosterol pathway. While the sterol composition
of most algae is well established, the recent availabil-
ity of full genomes allows a detailed reconstruction
of the sterol metabolic pathways.
Our aim was to study sterol biosynthesis in four
unicellular, freshwater green algae. Our approach
took advantage of well-characterized inhibitors
which block sterol production in fungi, leading
either to an accumulation of sterol precursors or to
a different suite of sterols. Here, we report the
sterol composition of four green algae: Chlorella vari-
abilis NC64A, Chlorella sorokiniana, Chlamydomonas
reinhardtii, and Coccomyxa subellipsoidea. A major dif-
ference among these algae was that ergosterol was
the major sterol in both the Chlorella spp. and C.
reinhardtii, whereas C. subellipsoidea did not have
ergosterol but contained three phytosterols instead.
Using the sterol biosynthetic pathways identified in
Arabidopsis thaliana, (Benveniste 2004), Saccharomyces
cerevisiae (Parks and Casey 1995, Mo and Bard
2005), and C. reinhardtii (Brumfield et al. 2017) as
plant, fungal, and algal models, respectively, we
describe an ergosterol biosynthetic pathway present
in both Chlorella spp. This pathway fits with the
modified sterols and sterol precursors observed
following treatment with the antibiotics ketocona-
zole and clotrimazole. Finally, we tackled the plant-
like sterol composition of C. subellipsoidea by multi-
ple sequence alignment of relevant oxidosqualene
cyclase proteins. We identified 22 residues where
the 3 ergosterol-containing algae used one amino
acid while C. subellipsoidea and the A. thaliana CAS
used another.
MATERIALS AND METHODS
Cell cultures and growth conditions. All species were grown
under normal growth conditions as follows. Chlorella variabilis
NC64A and Coccomyxa subellipsoidea cultures were grown in
modified Bolds basal medium (MBBM; Van Etten et al. 1983)
shaken at 100 RPM, 22°C, and a light intensity of 30 µE.
Chlorella sorokiniana UTEX 1230 was obtained from the
University of Texas Culture Collection and grown in liquid
Bolds Basal Medium (BBM; Nichols and Bold 1965), shaken
at 115 RPM, 25°C, and a light intensity of 58 µE. Chlamy-
domonas reinhardtii CC124, obtained from Dr. Donald Weeks,
was grown in Tris-Acetate-Phosphate medium (Gorman and
Levine 1965), shaken at 100 RPM, 22°C, and a light intensity
of 30 µE. Cell abundance was determined using a Coulter
Multisizer II instrument (Beckman Coulter, Fullerton, CA,
USA).
Sterol standards and inhibitors. A plant sterols kit (cat.
#1123, Matreya, Pleasant Gap, PA, USA) was used for stan-
dards. Cholestanol (1 mg  mL-1) was used as a sterol inter-
nal standard for GC-MS analysis. Obtusifoliol was a gift
from Prof. David Nes, Texas Tech University. Antifungal
inhibitors Atorvastatin (A7658), Terbinafine (T1672), Clotri-
mazole (C4657), Ketoconazole (K1676), and Fluconazole
(F4682) were purchased from LKT Laboratories (St. Paul,
MN, USA). Thiolutin was obtained from Tocris Bioscience
(Bristol, UK).
Sterol extraction and analysis by gas chromatography-mass spec-
trometry (GC/MS). Sterols were extracted in triplicate by
chloroform-methanol, purified by silica-solid phase extrac-
tion, and analyzed by GC/MS. One mg/ml of cholestanol
standard (Matreya, Pleasant Gap, PA, USA) was added to
freeze-dried algal pellets followed by extraction three times
with chloroform: MeOH (1:1, v:v). Samples were dried in a
stream of nitrogen, dissolved in chloroform, and loaded
onto silica SPE columns. A purified sterol fraction was
eluted from the column with 30% 2-propanol in hexane.
Purified sterol extracts were dried under nitrogen and then
converted to trimethylsilyl ether (TMS-ether) derivatives
using bis (trimethylsilyl) trifluoracetamide (BSFTA-TMCS
99:1; Sigma, St. Louis, MO, USA). Dried sterol samples were
suspended in 100 µl hexane for GC/MS analysis. Initial gas
chromatographic analysis was carried out using the Agilent
6890 Series Gas Chromatograph System equipped with a
DB-5ms capillary column (30.0 m x 250.00 µm, 0.25 µm,
J&W 122-5532, J&W Scientific, Inc., Folsom, CA, USA).
Helium was the carrier gas at a linear velocity of 48 cm/sec
and constant flow of 1.5 mL  min-1. A dual ramp tempera-
ture program was used with the oven heated from 250 to
270°C for 30 min and then from 270 – 280°C for 3.5 min.
The detector temperature was 270°C. Sterols were initially
identified using the NIST98 library (Scientific Instrument
Services, Inc., Ringoes, NJ, USA) followed by comparisons
to published spectra based on their mass fragmentation pat-
terns and retention times (see Table 1). Peak areas of iden-
tified sterols were quantified relative to the cholestanol
standard. Values reported are the average of triplicate
experiments.
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Growth curves and MIC values. The inhibitory concentra-
tions of terbinafine and the azole drugs were determined
using methanol (MeOH) solutions of the drug ranging
from 0-50 mM. A culture of Chlorella sorokiniana was diluted
with fresh BBM to a final cell density of 1x106 cells  mL-1.
The culture was partitioned into 5 mL volumes and treated
with 5 µL of a given stock solution, which resulted in a
1:1000 dilution of the stock drug solution. Other samples
were treated with 5 µL of MeOH as solvent controls. Trials
were run in duplicate. After six days, the absorbance at
750 nm was measured via a Biotek Synergy H1 Hybrid
reader (Winooski, VT, USA). Inhibitory concentrations were
determined by graphing absorbance vs. drug concentration
and identifying the lowest concentrations at which growth
was inhibited. Growth curves were similar in design except
that absorbance was read every day. To determine if a given
drug was algicidal (killing the algal cultures) or algistatic
(merely arresting cell growth), cultures that had been inhib-
ited for 2-3 d were centrifuged at 4200 RPM for three min
and then transferred into 5 mL of fresh BBM media to
allow growth.
Sterol biosynthesis inhibition. Algal cultures were grown to
mid-log phase (ca. 1x106 cells  mL-1). The sterol inhibitors
were added to each culture at final concentrations of 100 µM
atorvastatin, 4 µM terbinafine, 30 µM ketoconazole, and
5 µM clotrimazole. These concentrations were chosen based
on the MIC values and growth inhibition we observed for C.
sorokiniana. For terbinafine, ketoconazole, and clotrimazole,
the concentrations were slightly higher than those needed
for 50% inhibition of cell growth while for the noninhibitory
atorvastatin, 100 µM was the highest concentration tested.
Methanol (0.1%) was added to control cultures. Algal cul-
tures were incubated for an additional 48h before cells were
harvested by centrifugation. Pelleted algal cells were freeze-
dried and stored at 80°C for further analysis of their sterol
composition. Peaks were identified based on their retention
times and MS fragmentation patterns (Table 1). Values
reported are the average of triplicate experiments.
Sequence retrieval. The complete Chlorella variabilis genome
assembly (http://genome.jgi.psf.org/ChlNC64A_1/ChlNC64A_
1.home.html;v1.0; Blanc et al. 2010) was used to search and
identify sterol biosynthetic pathway genes as well as the
recently sequenced and annotated Chlorella sorokiniana UTEX
1230 genome (H.D. Cerutti, unpub. data). The genomes for
Arabidopsis thaliana (NCBI taxon ID: 3702), Chlamydomonas
reinhardtii (NCBI taxon ID: 3055), and Coccomyxa subellipsoidea
(NCBI taxon ID: 574566) were accessed through the National
Center for Biotechnology Information (http://www.ncbi.nlm.
nih.gov/). Saccharomyces cerevisiae (NCBI taxon ID: 4932)
ergosterol (ERG) genes were used to identify homologues
and elucidate the ergosterol pathway in C. variabilis. The
number of transmembrane domains for each protein in each
species was predicted using version 2.0 of TMHMM
(Sonnhammer et al. 1998).
Phylogenetic analysis. The 2,3-oxidosqualene cyclase (OSC)
sequences used for the phylogenetic analyses were taken from
the results of a BLASTp search (version 2.2.30) against the
nonredundant protein database using default settings
(Altschul et al. 1990). Sequences from lanosterol-producing
vertebrates and fungi as well as cycloartenol-producing plants,
diatoms, and algae were chosen to represent a broad repre-
sentation of each lineage. The squalene-hopane cyclase from
Acetobacter tropicalis was included as an out-group to derive the
root of the tree, but not shown in the final phylogeny to
maintain readability due to its divergence from the eukaryotic
OSC genes. The protein sequences were globally aligned
using version 7.402 of MAFFT (Katoh et al. 2019). The maxi-
mum likelihood phylogenic tree was produced with version
20120412 of PhyML with 1000 bootstrap pseudoreplicates
(Guindon et al. 2010).
TABLE 1. Retention times of sterol standards.
Sterol standard Rfa m/z (TMS-ether) PubChem CID NIST
Ergostatetraenol 1.14 466 23724485 17866
Ergosterol 1.15 468 444679 23726
Campesterol 1.17 472 173183 331835
14a-Methylergosta-8,24(28)-dienolb 1.18 484
14a-Methylergost-8-enolb 1.21 486 129703316
Stigmasterol 1.22 484 5280794 331824
Ergosta-5,7,24(28)-trienolc 1.23 468 42608412 23726d
Ergosta-5,7-dienol 1.27 470 5326970
Ergost-7-enol 1.32 472 5283646 17938
7-Dehydroporiferasterol 1.33 482 20843308 17146e
4a,14a-Dimethylergosta-8,22-dienol 1.33 498 101614321
Obtusifoliol 1.37 498 65252 16573
b-sitosterol 1.37 486 222284 331677
24(28)-Dihydroobtusifoliolf 1.39 500 23258269
Cycloartenol 1.40 500 313075
24(28)-Dihydrocycloeucalenol 1.56 500 6427296g
24-Methylenecycloartenol 1.57 512 94204
24-Methylcycloartenol 1.62 514 13784482
9,19-Cyclolanost-25-en-3b-ol, 24-methyl 1.66 512
Cyclolaudenol 1.75 512 101729
aRelative to cholestenol standard.
bDoyle et al. (1971).
cRetention time from Zhou et al. (2006).
dIsomer.
eSpectrum of free alcohol.
fBowden and Palmer (1975).
gRefers to acetate derivative.
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OSC structure prediction. The tertiary structure of the Coc-
comyxa subellipsoidea CAS protein was predicted using the
template-based structure prediction from the RaptorX web-
server (K€allberg et al. 2012). The predictions were based pri-
marily on the human OSC in complex with lanosterol (PDB
1W6K). The key structures were confirmed using the
template-free contact prediction from the RaptorX webserver
(Wang et al. 2017). The predicted structure was visualized and
annotated using version 2.3.2 of PyMOL (Schr€odinger 2019).
RESULTS
We took a 4-prong approach to study sterol
biosynthesis in four unicellular algae. We deter-
mined [A] which sterols were synthesized under
standard growth conditions, [B] which of six known
antifungal inhibitors were also inhibitory toward the
microalgae, [C] how these inhibitors influenced the
sterol compositions of the respective algae, and [D]
which homologs of known sterol biosynthetic genes
from Arabidopsis thaliana, Saccharomyces cerevisiae, and
Chlamydomonas reinhardtii were present in C. subellip-
soidea, C. variabilis and C. sorokiniana.
Sterol composition of four microalgae. The major ster-
ols were identified by GC/MS for four unicellular,
freshwater green algae Chlorella variabilis, C. sorokini-
ana, Chlamydomonas reinhardtii, and Coccomyxa subel-
lipsoidea. Four different patterns were observed
(Table 2). Chlamydomonas reinhardtii and the two
Chorella sp. contained ergosterol as the dominant
sterol. Chlamydomonas reinhardtii contained ergos-
terol (63%), ergost-7-enol (10%), and 7-
dehydroporiferasterol (27%; Table 2). Note that
ergosterol (C24ß-methyl) and 7-
dehydroporiferasterol (C24ß-ethyl) differ by only a
single carbon. Our results for C. reinhardtii serve as
an internal control in that they confirm prior
reports of ergosterol and 7-dehydroporiferasterol as
the major sterols (Miller et al. 2012, Brumfield
et al. 2017). The distinction between C. variabilis
having both ergosterol and ergostatetraenol and C.
sorokiniana having ergosterol only (Table 2) reflects
in part the absence of the final enzyme C-24 (28)
sterol reductase in C. variabilis (Table 3) with the
concomitant necessity of recruiting a less efficient
reductase to make ergosterol. Ergostatetraenol is
the precursor for ergosterol (Fabris et al. 2014, Ber-
kow et al. 2015, Brumfield et al. 2017; Fig. 1) and
the two molecules have very similar retention times
by GC/MS (Table 1). Thus, a small difference in
the % completion of the last step could determine
whether ergostatetraenol appeared as a separate
peak (C. variabilis) or as a shoulder on the ergos-
terol peak (C. sorokiniana). In contrast, C. subellip-
soidea resembled the vascular plants because it only
contained the phytosterols campesterol (48%), b-
sitosterol (43%), and stigmasterol (9%; Table 2).
Sensitivity to known antimycotic compounds. Chlorella
sorokiniana cultures (1x106 cells  mL-1) were tested
for their sensitivity to six antifungal antibiotics, five
of which (terbinafine, clotrimazole, ketoconazole,
fluconazole, and atorvastatin) block sterol biosynthe-
sis in fungi (Macreadie et al. 2006), whereas thio-
lutin inhibits RNA polymerases. Two of the
antibiotics, fluconazole and atorvastatin, were not
inhibitory at any concentrations tested up to 50 and
100 µM, respectively. This finding is not surprising
for atorvastatin, a well-known inhibitor of HMG
CoA reductase used to lower cholesterol levels in
humans, because neither Chlorella sp. has the gene
for HMG CoA reductase (Table 3). For another
inhibitor, terbinafine, the cultures did not have dif-
fering sterol profiles, but, compared with the con-
trols, their total ergosterol levels decreased by ca.
40%, from 4.3 nmol  mg-1 to 2.5 nmol  mg-1 in C.
variabilis and 3.2 nmol  mg-1 to 2.0 nmol  mg-1 dry
weight for C. sorokiniana (Table 4). These results are
close to those of Lu et al. (2014) who reported a
20% decrease in total sterol content for terbinafine-
treated Nannochloropsis oceanica. Together these
observations are consistent with a mode of action
for terbinafine in algae identical with that estab-
lished in fungi, that is, inhibition of squalene epoxi-
dase. This mode of action would reduce the entry
of carbon into stage III of the sterol pathway but
not alter the remaining sterol profiles.
Terbinafine, clotrimazole, thiolutin, and keto-
conazole, blocked growth of Chlorella sorokiniana at
minimal inhibitory concentrations of 2, 2, 10, and
20 µM respectively. Each of these four active drugs
was algistatic rather than algicidal, in agreement
with the fungistatic nature of their activity toward
fungi (Odds et al. 1985). Thus, if their modes of
action in algae parallel those in fungi, terbinafine,
clotrimazole, and ketoconazole should be effective
inhibitors of algal sterol synthesis while thiolutin,
as a transcription inhibitor, would allow the deter-
mination of algal mRNA half-lives (Kebaara et al.
2006). The two inhibitory azoles, clotrimazole and
ketoconazole, are both imidazoles whereas flucona-
zole is a triazole, and this structural difference
may contribute to their sterol inhibition, or lack
thereof.
Sterol biosynthesis inhibition. The azole antifungals
inhibit key enzymes in sterol biosynthesis, leading to
the accumulation of diagnostic intermediates that
allow us to study the intermediates, and in doing so
better understand their sterol biosynthetic pathways.
Thus, Chlorella sorokiniana, C. variabilis, Chlamy-
domonas reinhardtii, and Coccomyxa subellipsoidea were
treated with clotrimazole (5 µM) and ketoconazole
(30 µM). These concentrations were chosen to be
slightly higher than those needed for 50% inhibi-
tion of cell growth for C. sorokiniana in liquid cul-
ture. Methanol-only controls were used in each case.
Although the clotrimazole and ketoconazole con-
centrations were chosen based on their activity
toward C. sorokiniana, their general suitability for
the other green algae is shown by their dramatically
altered sterol profiles in all cases (Tables 4 and 5,
Table S1 in the Supporting Information).
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In Chlorella sorokiniana, the decreased ergosterol in
the ketoconazole treated cells was accompanied by
the appearance of 10% obtusifoliol, 18% 14a-
methylergosta-8,24(28)-dienol (also known as 4-
desmethyl obtusifoliol), and 24% 14a-methylergost-
8-enol (Table 4). This observation is consistent with
ketoconazole inhibiting the P450 CYP51 C-14
demethylase whose normal substrate is obtusifoliol
(step 4 in Fig. 1). CYP51 is an ortholog of ERG 11,
the primary target of the azole drugs in fungi. Thus,
inhibition of CYP51 leads to the accumulation of
obtusifoliol and subsequent conversion to 14-
methylergost-8-enol by the combined action of Erg
4/24 and the SM02/BSD1/Erg28 complex, acting in
either order. Next, the sterols detected in clotrima-
zole treated cells (Table 4) suggest that clotrimazole
inhibits CYP710, the P450 C-22 sterol desaturase, as
well as CYP51 because clotrimazole treated cells also
accumulated ergost-7-enol and ergost-5,7-dienol
(Table 4). Inhibition of CYP710 (step 8 in Fig. 1)
would lead to the accumulation of episterol and
ergosta-5, 7, 24 (28) trienol which can both act as
substrates for Erg 4/24, being converted to ergost-7-
enol and ergosta-5, 7-dienol, respectively (Fig. 1).
The sterol profiles for Chlorella variabilis following
azole treatment are very similar to those for C.
sorokiniana (Table 4) but in this case ketoconazole
also appears to inhibit CYP710 as well as CYP51. Pre-
viously, Doyle et al. (1971) noted that triparanol-
treated Chlorella emersonii accumulated both 14-
methylergost-8-enol and 14-methylergosta-8, 24 (28)-
dienol while Chan et al. (1974) observed that
triparanol-treated C. sorokiniana accumulated large
amounts of ergost-7-enol and ergost-8-enol in addi-
tion to their normal ergosterol and ergosta-5,
7-dienol.
The sterol inhibition patterns for the other two
algae were more complicated. For Chlamydomonas
reinhardtii, ketoconazole and clotrimazole dramati-
cally reduced the levels of both ergosterol and
ergost-7-enol with the concomitant appearance of
several intermediates from the cycloartenol side of
the oxidosqualene cyclase pathway (Table S1). How-
ever, the levels of 7-dehydroporiferasterol remained
relatively unchanged. At present we have no
explanation for the different responses of the two
major sterols in C. reinhardtii. Finally, in the pres-
ence of the azoles, Coccomyxa subellipsoidea, which
normally synthesizes the phytosterols campesterol,
stigmasterol, and b-sitosterol (Table 5), produced
seven new intermediates from the cycloartenol path-
way including obtusfoliol and cyclolaudenol. We will
revisit why C. subellipsoidea synthesizes a different
suite of sterols a little later when we analyze the
amino acid sequence of the Coccomyxa CAS1.
Sequence retrieval and curation. Protein sequences
from known Arabidopsis thaliana sterol biosynthetic
genes were used in BLASTp searches against the
Chlorella sorokiniana genome to identify their ortho-
logs. The C. sorokiniana protein sequences identified
were then used in BLASTp searches against the
remaining algal sequences to identify their ortho-
logs in each species. All of the identified orthologs
were used in reciprocal BLASTp searches of the
NCBI database to confirm the identities of these
genes. Genes for sterol biosynthesis in the three
model systems, Arabidopsis thaliana, Saccharomyces cere-
visiae, and Chlamydomonas reinhardtii, are shown in
Tables S2 and S3 in the Supporting Information
while the biosynthetic genes for the four unicellular
algae are in Table 3. Complete BLASTp statistics
along with values for gene length in amino acids, %
GC content, % identity, and numbers of exons and
transmembrane domains are shown in Tables S4-S7
in the Supporting Information, for C. sorokiniana
(Table S4), C. variabilis (Table S5), C. reinhardtii
(Table S6), and Coccomyxa subellipsoidea (Table S7).
Similar data for the model systems A. thaliana and
S. cerevisiae are in Tables S3 and S8 in the Support-
ing Information, respectively. The gene lengths and
% GC values are consistent with the respective
genes being orthologs to one another, with no indi-
cation of their arrival by horizontal gene transfer.
The sterol biosynthetic genes were compared in
three groups: Stage 1, forming isopentenyl
pyrophosphate (IPP); Stage 2, IPP to 2,3-
oxidosqualene; and Stage 3, oxidosqualene to com-
pletion. For stage 1, Arabidopsis thaliana has both
the plastid-localized MEP pathway and the cytosolic
MVA pathway, while the yeast Saccharomyces cerevisiae
TABLE 2. Percentage of major sterols in four microalgae.












Total Sterols (nmol  mg dw-1) 2.5 3.2 3.6 3.4
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has only the cytosolic MVA pathway (Table S2). In
contrast, all of the algae lack the last four enzymes
(HMGR, MK, PMK, and MVD) of the MVA pathway
including HMG CoA reductase; instead, they only
contain the plastidal MEP pathway for IPP synthesis
(Table 3). The absence of HMG CoA reductase was
supported by the negligible effect of atorvastatin on
growth and sterol production (as previously dis-
cussed), suggesting that Chlorella spp. only use the
plastidic MEP pathway to produce IPP (Table 3).
This feature was also demonstrated for Chlamy-
domonas reinhardtii by Schwender et al. (1997) and
for the diatom Haslea ostrearia by Masse et al.
(2004); however, Fabris et al. (2014) showed that
the diatom Phaeodactylum tricornutum retained and
used the MVA pathway to make IPP.
Stage 2 of sterol biosynthesis – IPP to 2, 3-
oxidosqualene – has three enzymatic steps and
homologous genes were present in the three model
systems (Table S2) and all four of the algae for each
of these steps (Table 3). Thus, our data agree with
the conclusion from Benveniste (2004) that the
biosynthetic pathway from IPP to 2, 3-oxidosqualene
is the same in all eukaryotes.
For stage 3, from 2, 3-oxidosqualene to comple-
tion, there are at least six points of interest: 1/ Ara-
bidopsis thaliana has two oxidosqualene cyclase
(OSC) genes, designated CAS1 for cycloartenol syn-
thase and LAS1 for lanosterol synthase (Tables S2
and S3), while the other organisms have only one.
The yeast Saccharomyces cerevisiae has ERG7, a lanos-
terol synthase (Tables S2 and S8), while the four
algae have only a single cycloartenol synthase
(Table 3). The assignment of these algal genes as
CAS rather than LAS is based primarily on their
functionality and the chemical identity of their
downstream products and is supported by the bioin-
formatic analyses shown later. 2/ The presence of




reinhardtii Chlorella sorokiniana Chlorella variabilis
Coccomyxa
subellipsoidea
Stage I plastid - MEP Pathway
1-deoxy-D-xylulose 5-phosphate synthase Cre07.g356350 (736) sca185.g101550 (712) 59788 (721) 16525 (733)
1-deoxy-D-xylulose 5-phosphate
reductoisomerase
Cre12.g546050 (456) sca079.g101000 (469) 29723 (456) 47418 (476)
2-C-methyl-D-erythritol 4-phospate
cytidyltransferase
Cre16.g679669 (320) sca011.g102250 (304) 141910 (168) 35670 (260)
4-diphosphocytidyl-2-C-methyl-D-erythritol kinase Cre02.g145050 (348) sca085.g104500 (366) 33454 (354) 35952 (301)
2-C-methyl-D-erythritol 2,4-cyclo-
diphosphate synthase
Cre12.g503550 (208) sca055.g102250 (140) 12213 (167) 18339 (208)
1-hydroxy-2-methyl-2E-butenyl-4-
diphosphate synthase
Cre12.g490350 (682) sca127.g100200 (1157) 144676 (699) 27377 (749)
4-hydroxy-3-methyl-2E-butenyl-4-
diphosphate reductase
Cre08.g372950 (466) sca012.g106300 (402) 59658 (506) 53820 (439)
Isopentenyl pyrophosphate isomerase Cre11.g467544 (254) sca136.g102550 (306) 53578 (244) 36851 (230)
Stage I cytosol - MVA pathway
Acetoacetyl-CoA thiolase Cre02.g146050 (491) sca243.g102350 (533) 27161 (401) 37141 (404)
3-Hydroxy-3-methylglutaryl-CoA synthase Cre16.g678850 (718) sca110.g104250 (476) 138158 (513) 27385 (520)
3-Hydroxy-3-methylglutaryl-CoA reductase N.F. N.F. N.F. N.F.
Mevalonate kinase N.F. N.F. N.F. N.F.
Phosphomevalonate kinase N.F. N.F. N.F. N.F.
Mevalonate diphosphate decarboxylase N.F. N.F. N.F. N.F.
Stage II ER
Farnesyl diphosphate synthetase Cre03.g207700 (361) sca140.g100250 (358) 33543 (347) 22862 (340)
Farnesyl diphosphate farnesyl transferase Cre03.g175250 (462) sca085.g101650 (437) 11287 (187) 35284 (348)
Monooxygenase/hydrolase
(squalene epoxidase)
Cre17.g734644 (524) sca094.g100900 (545) 137251 (525) 53930 (509)
Stage III ER
Cycloartenol synthase Cre01.g011100 (763) sca081.g101700 (695) 22200 (762) 54267 (754)
Lanosterol synthase N.F. N.F. N.F. N.F.
Sterol C-24 methyltransferase Cre12.g500500 (388) sca033.g100850 (412) 26131 (333) 27964 (389)
Cycloeucanol cycloisomerase Cre16.g657300 (276) sca047.g103200 (298) 11379 (282) 65481 (298)
Sterol C-14 demethylase Cre02.g092350 (496) sca139.g104650 (498) 142513 (613) 54016 (492)
C(8,7) sterol isomerase Cre12.g557900 (219) sca034.g101250 (297) 34496 (224) 13584 (235)
C-4 sterol methyl oxidase Cre06.g261200 (308) sca222.g101000 (518) 57760 (290) 11014 (308)
C-3 sterol dehydrogenase Cre12.g518650 (402) sca089.g108000 (277) 49861 (361) 54657 (357)
3-keto sterol reductase N.F. N.F. N.F. N.F.
Endoplasmic reticulum protein Cre13.g567901 (74) sca039.g105150 (149) 59539 (149) 14819 (124)
C-5 sterol desaturase Cre16.g663950 (346) sca134.g102400 (337) 37407 (286) 15746 (275)
C-22 sterol desaturase Cre11.g467527 (516) sca146.g107050 (528) 30281 (422) 29437 (539)
C-24 (28) sterol reductase Cre02.g076800 (426) sca232.g100350 (444) N.F. 26214 (436)
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the three genes CAS1, CPI1, and HYD1 in the gen-
omes for Chlorella sorokiniana, C. variabilis, Coccomyxa
subellipsoidea, and Chlamydomonas reinhardtii strongly
suggests that these algae use the higher plant
cycloartenol branch of sterol biosynthesis, which is
likely a general feature of the green algae. 3/ In
yeasts, the C-4 demethylation step is catalyzed by a
complex encoded by ERG 25, 26, 27, and 28; how-
ever, C. reinhardtii (Brumfield et al. 2017) and the
other algae have orthologs to ERG 25, 26, and 28,
but not to ERG 27 (Table 3). 4/ The ergosterol
biosynthetic pathway is composed of membrane-
associated enzymes assembled as a multi-enzyme
complex. In yeasts, the noncatalytic protein ERG28
functions as a scaffold protein, anchoring enzymes
and creating a “hub” for enzymatic interactions with
substrates (Mo and Bard 2005, Winkel 2009). We
have identified an ERG28 homolog in C. variabilis
(59539), C. sorokiniana (039.g105150.t1), and C.
subellipsoidea (141819) as well as in C. reinhardtii and
other algae (Brumfield et al. 2017). 5/ For C.
sorokiniana, the 11 genes for stages 1 and 2 are all
FIG. 1. Putative sterol pathway in Chlorella variabilis and Chlorella sorokiniana showing structures of the biosynthetic intermediates and
the enzymes which catalyze each step, starting for convenience with cycloartenol, the product of Cas1p. 1: SMT1-sterol C-24 methyltrans-
ferase; 2: SMO2-C-4 sterol methyloxidase; 3: CPI1-cycloeucanol cycloisomerase; 4: CYP51-sterol C-14 demethylase; 5: ERG4/24-C-24(28)
sterol reductase; 6: HYD1-C (8, 7) sterol isomerase; 7: STE1-C-5 sterol desatirase; 8: CYP710-C-22 sterol desaturase. The biosynthetic path-
way follows that suggested by Brumfield et al (2017) for C. reinhardtii, overlaid with our data showing the sterol intermediates which accu-
mulate following treatment with ketoconazole or clotrimazole, drugs thought to inhibit the two cytochrome P450 enzymes, CYP51 and
CYP710, here labeled 4 and 8, respectively. [Color figure can be viewed at wileyonlinelibrary.com]
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high % GC: they range from 63.6 to 70.8% GC,
averaging 67.1% GC. Similarly, the 11 predicted
genes for Stage 3 are also high % GC, ranging from
61.8 to 67.1% GC, averaging 65.1% GC (Table S4).
There are no apparent differences in % GC for the
genes encoding plastid-localized components versus
ER-localized components (Table S4). The only nota-
ble difference based on localization is the number
of transmembrane domains (Table S4). No further
conclusions can be drawn from these high % GC
values because the genomic GC value for C. sorokini-
ana is 63% GC. 6/ RNA-Seq experiments with C.
sorokiniana showed that all 22 of the predicted sterol
biosynthetic genes were expressed as full-length
transcripts during growth (W. Riekhof, unpub.
data). Thus, the direct gene comparison reinforces
the premise that the green algae as a group pro-
duce sterols using the cycloartenol pathway of
higher plants and algae rather than the lanosterol
pathway of fungi and animals.
Comparison of Chlorella sp., Coccomyxa subellip-
soidea, and Chlamydomonas reinhardtii. Sterol
biosynthesis in the two Chlorella spp. and Coccomyxa
subellipsoidea (Table 3) are very similar to Chlamy-
domonas reinhardtii both biochemically and
genetically (Table S2; Miller et al. 2012, Brumfield
et al. 2017). All four algae make IPP via the plastid
MEP pathway and are missing the cytosolic MVA
pathway (Table 3). Likewise, all four contain the
same suite of 14 stage II and III genes (Table 3).
These 14 genes (Tables S4-S7) are roughly equiva-
lent in their percent identity, length of coding
sequence, and number of introns present. One
notable exception is SMO2 (C-4 sterol methyl oxi-
dase), which stands out by being only 29% identical
between C. sorokiniana (Table S4) and C. reinhardtii
(Table S6). Additionally, C. sorokiniana is notable
for having several more exons (up to twice as many)
than the other species for nearly all sterol-related
genes, consistent with the increased number of
exons across the rest of its genome (Table S4).
Phylogenetic analysis of OSC. Saccharomyces cerevisiae
has a single oxidosqualene cyclase OSC (ERG 7)
which cyclizes 2, 3-oxidosqualene to make lanos-
terol, while Arabidopsis thaliana has 13 OSCs, one of
which (LAS1, At3g45130) makes lanosterol and
another (CAS1, At2g07050) makes cycloartenol
(Tables S2 and S3; Xue et al. 2012). To determine
the number of OSC genes in the four algae, we per-
formed BLASTp searches against all 13 A. thaliana
OSCs (Table S9 in the Supporting Information).
For all four species, the only significant hits to any
of the A. thaliana OSCs is the single OSC reported.
Additionally, in every case, the alignment for the
algal OSC protein is 5-6% higher with CAS1 than
LAS1.
To investigate the algal OSCs further, we con-
structed a phylogenetic tree for forty OSCs (Fig. 2).
The sequences separated into four clades or clus-
ters. The first included OSCs that preferentially pro-
duce the sterol precursor cycloartenol, forming the
branch for higher plants and algae. The second
clade included Metazoa using lanosterol, while the
third clade included the fungi using lanosterol. A
fourth clade included two OSCs from the diatoms
Thalassiosira pseudonana and Fistulifera solaris
(Fig. 2). All nine of the microalgal OSCs were part
of the cycloartenol-forming plant OSCs (Fig. 2).
The Chlorella spp. have ergosterol as their major
sterol (Table 2) and it is likely synthesized via CAS
TABLE 4. Antifungal inhibition of Chlorella spp. sterol biosynthetic pathway and resulting sterol compositions.
Chlorella sorokiniana Chlorella variabilis
Sterol Control Clotrimazole Ketoconazole Control Clotrimazole Ketoconazole
Ergostatetraenol 41.7% 24.1% 28.2%
Ergosterol 99% 57% 47% 53% 38.8% 44.3%
14a-Methylergosta-8,24(28)-dienol 1% 18% 17.8% 7.3%
14a-Methylergost-8-enol 24%
Ergosta-5,7,24(28)-trienol 2.3% 3.6%
Ergosta-5,7-dienol 13% 2.9% 6.9% 5.9%
Ergost-7-enol 1% 6% 0.4%
Obtusifoliol 22% 10% 8.8% 13.8%
Cyclolaudenol 2%
Total Sterols (nmol  mg dw-1) 3.2 2.6 2.6 4.3 3.5 4.0
TABLE 5. Antifungal inhibition of Coccomyxa subellipsoidea
sterol biosynthetic pathway and resulting sterol composi-
tions.
Sterol Control Clotrimazole Ketoconazole
Campesterol 48.1% 40.1% 31.7%
14a-Methylergost-8-enol 4.2%












Total Sterols (nmol 
mg dw-1)
3.6 4.6 3.7
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and cycloartenol because only cycloartenol/obtusifo-
liol intermediates were formed after inhibition by
ketoconazole and clotrimazole (Tables 4 and 5). It
is well known that single-site mutations in the Ara-
bidopsis thaliana CAS gene can produce lanosterol
instead of cycloartenol (Segura et al. 2002, Ben-
veniste 2004). However, as pointed out by Brumfield
et al. (2017), multiple sequence alignment shows
that the four algal OSCs all have the highly con-
served amino acids expected for cycloartenol syn-
thase (CAS) rather than for lanosterol synthase
(LAS; Fig. 3).
The Coccomyxa question. Coccomyxa subellipsoidea
appears to be intermediary between the other algae
and higher plants, both in its OSC phylogeny
(Fig. 2) and in its dramatically different sterol com-
position (Tables 2 and 6). Additionally, its % GC
composition ranges from 51 to 62% for the sterol
biosynthetic genes in the MEP pathway and from 49
to 63% for the genes for stages 2 and 3 (Table S7)
whereas the genes for the two Chlorella sp.
(Tables S4 and S5) were more tightly clustered
around their average values of 66% GC. To investi-
gate possible causes for this transition, we con-
ducted a multiple sequence alignment of the OSC
proteins from Arabidopsis thaliana (both CAS1 and
LAS1), Saccharomyces cerevisiae, and the four algae we
have studied (Fig. 3). The three residues used by
Brumfield et al. (2017) as characteristic of cycloarte-
nol directed synthesis (marked in orange) and the
catalytic aspartic acid (marked in blue) are identical
for the four algae and the A. thaliana CAS (Fig. 3),
and thus they cannot explain the synthesis of the
three phytosterols by C. subellipsoidea. Instead, we
have identified 22 amino acid positions in the CAS
protein that are differentially conserved. That is, the
C. subellipsoidea CAS and A. thaliana CAS1 have one
amino acid, but the three ergosterol-containing
algae have a different amino acid. These 22 amino
acids are shown in yellow on the multiple sequence
FIG. 2. Phylogenetic tree for 40 oxidosqualene cyclase (OSC) proteins showing the position of genes from 9 algal species relative to
their plant, animal, fungal, and diatom equivalents. Acetobacter tropicallis (not shown) was used as an out-group to derive the root.
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alignment (Fig. 3). Most of these 22 amino acids
are located either around the catalytic site or on the
outer surface of the protein (Fig. 4).
DISCUSSION
Unicellular algae as an evolutionary transition point
for sterols. The biosynthesis of sterols in animals,
fungi, and plants differs in terms of precursors,
enzymatic steps, and final sterol composition. It is
widely accepted that the major sterols present in
animals and fungi are cholesterol and ergosterol,
respectively, and that both employ the cytosol local-
ized MVA pathway leading to the 5-carbon precursor
IPP. Subsequent steps are shared in animals and
fungi up to lanosterol, after which a bifurcated
pathway produces their respective distinct sterols.
Plants differ in that they use the plastid-localized
MEP pathway to make IPP and then use the precur-
sor cycloartenol (instead of lanosterol) to produce a
wide array of phytosterols. Currently, algae have
been grouped with plants as producing cycloartenol
and utilizing the phytosterol biosynthetic pathway.
We studied ergosterol biosynthesis in Chlorella vari-
abilis NC64A and C. sorokiniana because of their
recently sequenced and annotated genomes (Blanc
et al. 2010; H.D. Cerutti, unpub. data). Coccomyxa
subellipsoidea was included because its sterol lipid
profile appears to be transitionary between algae
and plants, which is supported by the OSC phyloge-
netic analysis (Table 2). We combined these bioin-
formatic data (Table 3) with the antibiotic
inhibition of key steps in sterol biosynthesis
(Table 4) to create a putative ergosterol biosyn-
thetic pathway for C. variabilis and C. sorokiniana
(Fig. 1).
In terms of their sterol contents, unicellular algae
exhibit greater diversity than either multicellular
algae or plants. Our results emphasize the unique
position of the unicellular algae as an evolutionary
transition point for sterols and suggest that the uni-
cellular algae provide the evolutionary precursor for
FIG. 3. Multiple sequence alignment of OSC proteins presented in Tables 3 and S2. The three residues identified by Brumfield et al.
(2017) as conserved in CAS proteins are colored in orange. The catalytic aspartic acid (D483 for Arabidopsis thaliana) is colored in blue.
Residues that are conserved across Chlamydomonas reinhardtii, Chlorella sorokiniana, and C. variabilis but are differently conserved in A. thali-
ana CAS1 and Coccomyxa subellipsoidea are highlighted in yellow.
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the cycloartenol based pathways in higher plants
(Fig. 2; Haubrich et al. 2014, Vriet et al. 2015).
Sterol diversity. In addition to the four patterns we
observed in Table 2, previous studies on multicellu-
lar algae reported the presence of cholesterol in the
marine red algae and fucosterol in the marine
brown algae (Fieser and Fieser 1959) while Lu et al.
(2014) reported that the oleaginous microalga Nan-
nochloropsis oceanica had both cholesterol and fucos-
terol/isofucosterol as the major and minor sterols,
respectively. These general classifications were
extended by Duperon et al. (1983) to identify and
quantify the free sterols, sterol esters, steryl glyco-
sides, and acetylated steryl glycosides present in
marine algae. More recently, this evolutionary diver-
sity was illustrated by the studies of Rampen et al.
(2010) who examined 106 diatom cultures looking
for an unambiguous diatom biomarker. They
detected 44 sterols, of which 11 were major sterols
in that they comprised ≥ 10% of the total sterols in
one or more diatom. However, none of the major
sterols qualified as a diatom-specific biomarker
because all of them were common sterols in other
algae (Rampen et al. 2010).
In algae, the intricate roles and functions of ster-
ols are not completely understood. Our putative
pathway (Fig. 1) helps explain the diversity in ster-
ols in unicellular algae, which may contribute to
our understanding their specific functions. Factors
influencing sterol differences among algal species
could be morphological, environmental, or evolu-
tionary. From a morphological viewpoint, having an
alternating life cycle or multiple distinct cell types
may require distinct sterols, possibly using both
cycloartenol and lanosterol precursors. Different
membrane structures might also be related to
whether the algae had evolved as the photosynthetic
partner in a symbiosis, with the added complication
that both primary and secondary plastid endosymbi-
otic events may have occurred. From an
FIG. 4. Four views of the tertiary structure prediction of Coccomyxa subellipsoidea CAS. Positions are given for the residues on the C. subel-
lipsoidea sequence (Fig. 3). Yellow residues are conserved across Chlamydomonas reinhardtii, Chlorella sorokiniana, and C. variabilis, but are dif-
ferentially conserved in Arabidopsis thaliana CAS1 and C. subellipsoidea. The catalytic D480 residue is colored in blue. Residues identified by
Brumfield et al. (2017) as conserved in CAS proteins are colored in orange. 15 of the 22 differently conserved residues are shown. These
residues cluster on the outer surface of the protein and around the catalytic region and could alter the protein-protein binding of the
CAS proteins and/or reaction dynamics to explain the shift from ergosterol to phytosterol production in C. subellipsoidea.
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environmental perspective, water composition, tem-
perature, salinity, nutrient, and ion composition are
highly variable between freshwater and marine
ecosystems (Porsbring et al. 2009). For the algae we
have studied, Chlorella sorokiniana can grow at war-
mer temperatures than C. variabilis while Coccomyxa
subellipsoidea is unusual in that it can still grow at
extreme, near-polar temperatures. These tempera-
ture adaptations likely require different sterol com-
positions (Starr and Parks 1962).
Why ergosterol?. Changing environmental condi-
tions, such as light intensity and day length, have
been shown to change the ratio of sterols present in
higher plants (Rahier and Taton 1997). Algae
within the class Chlorophyceae have many species that
contain ergosterol and/or other D5, 7- sterols not
found in higher orders of algae and land plants
(Patterson et al. 1991). One idea is based on the
absorption spectrum of sterols containing two conju-
gated double bonds. The evolution away from cell
membranes containing D5, 7- sterols to those with either
D5 - or D7-sterols took place as the earth’s ozone
layer developed, because D5,7- sterols are more effi-
cient in absorbing UV radiation (Patterson et al.
1991). Indeed, ergosterol is commonly assayed by its
absorption at 280 nm. Hence, once the ozone layer
was established, the selective advantage of the D5,7-
sterols may have disappeared. Higher plants contain
a cocktail of three D5 phytosterols – campesterol
(24-methyl), stigmasterol (24-ethyl), and b-sitosterol
(24-ethyl) (Mercer 1993, Holmberg et al. 2002) and
this phytosterol composition also occurs in the uni-
cellular green alga Coccomyxa (Table 2). The size
and direction of the 24-alkyl group inserted by
sterol methyltransferase are indicative of either a
primitive (24 b-methyl) or advanced (24 a-ethyl)
organism (Zhou et al. 2007).
Another more recent idea is that the sterol compo-
sition may be constrained by the other aspects of an
interlocking membrane composition (i.e., the need
for sterols to partner with particular sphingolipids)
providing lipid rafts and other distinctive capabilities
for the algal membranes (Guan et al. 2009, Gulati
et al. 2010, Hannich et al. 2011). An attractive feature
of sterol-sphingolipid pairing is that it provides a
rationale why organisms as distinct, ecologically, evo-
lutionarily, and metabolically as algae and Saccha-
romyces utilize the same sterol, ergosterol.
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